1. Home
  2. IPO
  • Emcure Pharmaceuticals Ltd Ipo
16966
Off
emcure logo

Emcure Pharmaceuticals IPO

Emcure pharmaceuticals decided to join the IPO frenzy this year. It filed a DRHP with SEBI for an IPO worth between Rs.4500 crores to...

  • Status: Closed
  • RHP:
  • ₹ 13,440 / 14 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    10 Jul 2024

  • Listing Price

    ₹1,325.05

  • Listing Change

    31.45%

  • Last Traded Price

    ₹1,049.25

IPO Details

  • Open Date

    03 Jul 2024

  • Close Date

    05 Jul 2024

  • Listing Date

    10 Jul 2024

  • IPO Price Range

    ₹ 960 to ₹ 1008

  • IPO Size

    ₹ 1,952.03 Cr

  • Listing Exchange

    BSE, NSE

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

IPO Timeline

Emcure Pharmaceuticals IPO Subscription Status

Last Updated: 08 July 2024 9:50 AM by 5Paisa

Established in 1981, Emcure Pharmaceuticals Limited develops, manufactures, and markets various pharmaceutical products. The company’s product portfolio for R&D includes orals, injectables and biotherapeutics. The company has a global reach across 70 countries with a strong presence in India, Europe and Canada. It has a presence in most of the major therapeutic areas, including gynaecology, cardiovascular, vitamins, minerals and nutrients, HIV antivirals, blood-related and oncology/anti-neoplastics. 

It is the largest, 4th largest, and 14th largest company in India in terms of i) gynaecology and human immunodeficiency virus (HIV) antivirals therapeutic areas ii) by market share in our Covered Markets in terms of Domestic Sales for MAT for FY2024 and iii) by Domestic Sales for MAT for FY2024, respectively. 

The company has 548 qualified scientists and 5 dedicated R&D facilities in the country along with 220 patents as of FY2024. It also has 13 manufacturing units based in India.

Peer Comparison

●    Dr Reddy's Laboratories Limited
●    Cipla Limited
●    Alkem Laboratories Limited
●    Torrent Pharmaceuticals Limited
●    Mankind Pharma Limited
●    Abbott India Limited
●    J. B. Chemicals & Pharmaceuticals Limited

For More Information
Webstory on Emcure Pharmaceuticals IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY24 FY23 FY22
Revenue from operations 6658.25 5985.81 5855.38
EBITDA 1276.78 1220.94 1393.38
PAT 527.57 561.84 702.55
Particulars (in Rs. Crores) FY24 FY23 FY22
Total Assets 7806.16 6672.53 6063.46
Share Capital 181.15 180.85 180.85
Total Borrowings 4684.39 4022.87 3949.32
Particulars (in Rs. Crores) FY24 FY23 FY22
Net cash generated from / (used in) operating activities 1097.24 746.85 768.20
Net cash from / (used in) investing activities -712.51 -467.68 -788.79
Net cash flow from / (used in) financing activities -164.20 -145.39 -151.85
Net increase (decrease) in cash and cash equivalents 220.52 133.77 -172.43


Strengths

1. The company is well-placed in the domestic Market.
2. It has demonstrated the Capabilities of Building Brands.
3. It also has a Large, Diversified and Fast-Growing Product Portfolio in International Markets.
4. The company also has Strong R&D Capabilities and manufacturing facilities.
5. Experienced Board and senior management team.
 

Risks

1. The company is subject to extensive government regulations in India and international markets.
2. High working capital requirements.
3. It has reported negative cash flows in the past. 
4. Limited therapeutic areas contribute to a more significant portion of the total revenue in India.
5. Its international operations expose the company to complex management, legal, tax and economic risks.
6. Faces forex fluctuations risks. 
7. Its EBITDA and PAT have decreased in the last few financial years. 

Will You Apply for Emcure Pharmaceuticals IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Emcure IPO opens from 3rd July to 5th July 2024.
 

The size of Emcure IPO is ₹1,952.03 cr. 
 

To apply for Emcure IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for Emcure IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

You will receive a mandate notification to block funds in your UPI app.

The price band of Emcure IPO is set at ₹960 to ₹1008 per share.

The minimum lot size of Emcure IPO is 14 shares and the minimum investment required to apply for the IPO is ₹13,440.
 

The share allotment date of Emcure IPO is 8th July 2024.

The Emcure IPO will be listed on 10th July 2024.

Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited, and J. P. Morgan India Private Limited are the book-running lead managers for Emcure IPO. 

Emcure will use the proceedings from the public issue for: 

●    To repay or prepay in full or partial borrowings obtained. 
●    For general corporate purposes.